江滨, 廖鹏军. 吉妥珠单抗奥唑米星显著改善老年急性髓系白血病患者的总生存率[J]. 循证医学, 2017, 17(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2017.02.007
    引用本文: 江滨, 廖鹏军. 吉妥珠单抗奥唑米星显著改善老年急性髓系白血病患者的总生存率[J]. 循证医学, 2017, 17(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2017.02.007
    JIANG Bin, LIAO Peng-jun. Gemtuzumab Ozogamicin Significantly Improve Overall Survival in Elderly Patients with Acute Myeloid Leukemia[J]. Journal of Evidence-Based Medicine, 2017, 17(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2017.02.007
    Citation: JIANG Bin, LIAO Peng-jun. Gemtuzumab Ozogamicin Significantly Improve Overall Survival in Elderly Patients with Acute Myeloid Leukemia[J]. Journal of Evidence-Based Medicine, 2017, 17(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2017.02.007

    吉妥珠单抗奥唑米星显著改善老年急性髓系白血病患者的总生存率

    Gemtuzumab Ozogamicin Significantly Improve Overall Survival in Elderly Patients with Acute Myeloid Leukemia

    /

    返回文章
    返回